Company Overview and News
I am projecting AGNC will report a combined modest-notable net unrealized loss on available-for-sale securities and investment securities measured at FMV for the second quarter of 2018.
NYMTO ORC FNMA CHMI NYMTP CIM AI AI.PRB TWO AGNC AIW TWO.PRA TWO.PRB TWO.PRC MO WMC NRZ AIC NLY.PRECL CYS TRI MITT.PRB MITT.PRA CHMI.PRA MITT FMCKI FMCKJ MFA.PRA MFA.PRB CYS.PRA CYS.PRB CIM.PRA FMCCO FMCCP FMCCM IVR.PRA FMCCN IVR.PRB MFO IVR.PRC FMCCI DX NLY NLY.PRA FMCCJ FMCCG FMCKO FMCKP NLY.PRD FMCKM NLY.PRE FMCKN CIM.PRB FMCKK NLY.PRC FMCKL ARR NLY.PRF NLY.PRG MFA FMCC HTS IVR DX.PRB NYMT DX.PRA ARR.PRB ARR.PRA FMCCS FMCCT
JPMorgan Chase & Co (NYSE: JPM) came in with some bullish numbers this morning, with revenue up 18% for the most recent quarter. Not all the big banks were as bullish, but it does show that the financial sector is finally finding a way to make money more consistently without relying on the risky derivatives market.
PZBW LOB JPM BCML NRZ HLNE VIRT IBKR SIVB ENVA CIGI
Fairly similar to the prior quarter, I am projecting AGNC will report a modest-notable gain regarding the company’s derivative instruments and other securities for the second quarter of 2018.
CHMI.PRA NYMTO MTGE ORC CHMI NYMTP AI CYS.PRA AI.PRB CYS.PRB TWO AGNC AIW TWO.PRA TWO.PRB TWO.PRC NRZ AIC NLY NLY.PRA NLY.PRECL NLY.PRD NLY.PRE CYS NLY.PRC ARR NLY.PRF NLY.PRG NYMT ARR.PRB ARR.PRA
The economic calendar is a light one, and many regular participants are on vacation. The most important data include PPI, CPI, and JOLTS, the best read on a tightening labor market. I expect pundits to put these pieces together and wonder:
ROP TOL GIS NRZ RCL
New Residential Investment Corp. is a top-notch mortgage REIT with a promising investment portfolio. I see NRZ as a "Strong Buy".
This series projects AGNC’s income statement for the second quarter of 2018. These projections help readers understand how most of the fixed-rate agency mREIT sector performed.
CHMI.PRA NYMTO ORC CHMI NYMTP AI CYS.PRA AI.PRB CYS.PRB TWO AGNC AIW TWO.PRA TWO.PRB TWO.PRC NRZ AIC NLY NLY.PRA NLY.PRECL NLY.PRD NLY.PRE CYS NLY.PRC ARR NLY.PRF NLY.PRG HTS NYMT ARR.PRB ARR.PRA
Landmark Infrastructure flaunted top net gains, while Orchid Island Capital had highest yield. Top ten gainers, IVR, TWO,WSR, ORC, EARN, NRZ, DX, CHMI, AJX, & LMRK ranged 10.6%-42.6% 6/28/18.
CHMI.PRA NYMTO ORC CHMI NYMTP CYS.PRA CYS.PRB EARN TWO AGNC TWO.PRA TWO.PRB TWO.PRC AJXA IVR.PRA NRZ IVR.PRB IVR.PRC DX NLY NLY.PRA NLY.PRECL NLY.PRD NLY.PRE CYS NLY.PRC NLY.PRF NLY.PRG IVR DX.PRB NYMT DX.PRA AJX
Investors focused on the Finance space have likely heard of New Residential Investment (NRZ - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Finance peers, we might be able to answer that question.
AGNC Investment Corp (AGNC) has a double-digit dividend yield, but this seems to be too risky because its sustainability is highly questionable.
NIM FNMA FMCKI FMCKJ AMBKP AGNC ACAS FMCCO FMCCP FMCCM FMCCN NRZ FMCCI NLY FMCCJ NLY.PRA FMCCG FMCKO FMCKP NLY.PRECL NLY.PRD FMCKM FMCKN NLY.PRE FMCKK NLY.PRC FMCKL NLY.PRF NLY.PRG FMCC FMCCS FMCCT
Here at Zacks, we don’t generally classify stocks as “cheap” or “expensive”, and rather than looking at the stock’s face value, we have a system that puts an emphasis on earnings estimate revisions to find stocks that will hopefully be winners for investors.
CVGI BGFV ELY AUDC CY NRZ CFCO CFCOW CFCOU GRPN ZAGG FG TERP
REIT headwinds persist, including rising interest rates and bond yields, as well as the pro-growth, risk-on environment.
REG GEO BPY ARI EPR.PRG O.PRF OPRF KRG UMH.PRD UMH.PRC UMH.PRB UMH.PRA AI LADR EQR AI.PRB CORR.PRA GGP UMH AIW AVB CORR REG.PRG REG.PRF ARI.PRA NRZ ARI.PRC AIC O NLY NLY.PRA NLY.PRECL NLY.PRD NLY.PRE GGP.PRA NLY.PRC NLY.PRF NLY.PRG EPR CBL
This article compares NLY’s recent dividend per share rates, yield percentages, and several dividend sustainability metrics to twenty mREIT peers.
ANH.PRA ANH.PRC ANH.PRB ANH NYMTO IRC ORC CHMI NYMTP AI AI.PRB CMO TWO AGNC AIW TWO.PRA TWO.PRB GPMT TWO.PRC WMC NRZ AIC NLY.PRECL CYS 511505 CAPITALT MITT.PRB MITT.PRA CHMI.PRA MITT MFA.PRA MFA.PRB CYS.PRA CYS.PRB IVR.PRA IVR.PRB MFO IVR.PRC DX NLY NLY.PRA NLY.PRD NLY.PRE NLY.PRC ARR NLY.PRF BXMT NLY.PRG MFA IVR DX.PRB NYMT DX.PRA ARR.PRB ARR.PRA CMO.PRE
9h - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
Silicon Investor Message Boards
This table lists all message boards related to NRZ / New Residential Investment Corp. on message board site Silicon Investor.
|SNRZ Sunrise Assited Living, Inc|
as of ET